Trroy Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-10-2024
- Paid Up Capital ₹ 0.15 M
as on 23-10-2024
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 102.91%
(FY 2023)
- Profit 26.93%
(FY 2023)
- Ebitda 80.15%
(FY 2023)
- Net Worth -22.10%
(FY 2023)
- Total Assets 8.80%
(FY 2023)
About Trroy Life Sciences
The Corporate was formerly known as Phloem Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Anjan Roy, Trishna Roy, Tanushree Roy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230KA2010PTC054629
- Company No.
054629
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jul 2010
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- LocationBangalore, Karnataka
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Trroy Life Sciences Private Limited offer?
Trroy Life Sciences Private Limited offers a wide range of products and services, including Research and Development (R&D) Work, Product Development Research.
Who are the key members and board of directors at Trroy Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjan Roy  | Director | 30-Jul-2010 | Current |
| Trishna Roy | Director | 30-Jul-2010 | Current |
| Tanushree Roy | Director | 28-Mar-2012 | Current |
| Sumitra Roy | Director | 12-Nov-2014 | Current |
Financial Performance of Trroy Life Sciences.
Trroy Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 102.91% increase. The company also saw a substantial improvement in profitability, with a 26.93% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trroy Life Sciences?
In 2023, Trroy Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ray Life Sciences Private LimitedActive 33 years 3 monthsAnjan Roy, Trishna Roy and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trroy Life Sciences?
Trroy Life Sciences has a workforce of 35 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trroy Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trroy Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
